Vascular Medicine Fellowship

Thank you for your interest in the University of Michigan Vascular Medicine Fellowship program. Our goal is to help aspiring vascular medicine clinicians develop into excellent clinicians and to further their academic interests. At the Frankel Cardiovascular Center, we have a diverse and internationally recognized faculty practicing in a state-of-the-art facility on the campus of world leading university.

Our vascular medicine fellowship training draws from strengths in a broad array of disciplines, including cardiovascular medicine, vascular surgery, cardiac surgery, interventional radiology. In addition to their clinical training, fellows have the opportunity to become actively involved in any number of research projects, ranging from basic and translational sciences to clinical and health services projects.

We appreciate your interest in our program and look forward to meeting you!

Sincerely,

Geoffrey Barnes, MD, MSc, Fellowship Director
Yogen Kanthi, MD, Fellowship Co-Director
James Froehlich, MD, MPH, Director of Vascular Medicine


DIVERSITY, EQUITY, AND INCLUSION IDENTITY STATEMENT

We, at the Frankel Cardiovascular Center, believe that delivering the very best heart and vascular care in the world can only be achieved through a culture of respect for one another and by celebrating the diversity of our patients, their families, and our workplace community. We strive to inspire an equitable and inclusive environment that welcomes and respects individuals from all races, ethnicities, gender identities, religions, beliefs, abilities, appearances, sexual orientations, and socioeconomic backgrounds. Diversity is at the heart of our values, improving patient outcomes, enhancing our work culture and optimizing health care.

Apply

Thank you for your interest in the Vascular Medicine Fellowship at the University of Michigan. This one-year, non-invasive fellowship prepares fellows to sit for the American Board of Vascular Medicine examination. While the board certification is designed for internal medicine physicians (both general internal medicine and specialists), we welcome applications from any physician with a strong interest in the care of patients with vascular disorders.

With a strong focus on vascular laboratory study interpretation, fellows will also be prepared to sit for the Registered Physician in Vascular Interpretation (RPVI) certification examination at the end of their training.

Applications can be submitted by e-mail to Bruce Skinner by November 15, 2020.  Please include the following in your application:

  • Current CV
  • Letter of interest or personal statement
  • Two (2) letters of recommendation
  • One (1) letter of recommendation from your most recent program director, assistant program director, or direct supervisor (if not currently in residency/fellowship)

Interviews will be conducted by Zoom. If you have questions during the application process, please do not hesitate to contact us:

Bruce Skinner, Program Coordinator 
734-998-7500 (phone)

Curriculum

The one-year fellowship program consists of both inpatient and outpatient training across a broad set of disciplines. In addition to the rotations, fellows will participate in a continuity clinic with one or more of the vascular medicine faculty.  All clinical work is conducted at Michigan Medicine, the University of Michigan health system. This includes the Frankel Cardiovascular Center, University Hospital, and select off site clinic locations.

Research

Health Services Research

Drs. Barnes and Froehlich run a multi-center quality collaborative focused on anticoagulation care. This includes a registry of over 15,000 patients on oral anticoagulants. Dr. Barnes is also a core faculty member at the Institute for Healthcare Policy and Innovation, where he has access to many large datasets (including Medicare, OptumInsight, Marketscan). Dr. Froehlich is director of the Michigan Clinical Outcomes Research and Reporting Program, where the International Registry of Aortic Dissection and many other outcomes registries are managed. Drs. Barnes and Froehlich have each mentored countless trainees on a variety of research projects, supported by a large team of research coordinators and statistical analysts.

Basic and Translational Research

Trainees will have access to the considerable breadth and depth of expertise of all vascular biology and thrombosis investigators at the University of Michigan. The U-M Cardiovascular Center houses one of the premier basic and translational thrombosis research programs in the country, with expertise in coagulation, platelet biology, thrombo-inflammation, and chronic pulmonary thrombo-embolic disease. Drs. Kanthi, Ganesh, and Hofmann each run highly productive basic and translational research labs with a strong track record for mentoring trainees. Their vascular research labs in the Cardiovascular Research Institute are adjacent to one another for added synergies and collaboration. Dr. Kanthi’s translational research lab has a footprint on both, the National Institutes of Health campus and the University of Michigan. His research team studies molecules at the intersection of inflammation and thrombosis with a focus on deep vein thrombosis and pulmonary embolism. Trainees will have access to unique potential opportunities for experience in translational investigation of vascular disease. Dr. Ganesh’s lab focuses of hypertension and genetic arteriopathies, including fibromuscular dysplasia. Dr. Ganesh leads the Michigan Biological Research on Sex differences in Cardiovascular Disease program (M-BRISC). Dr. Hofmann’s lab focuses on aortopathies, including aortic dissection and aneurysm. Dr. Hofmann is also the Director of the Aortic Diseases program.

All vascular medicine trainees will be provided with 4 weeks of dedicated research time and will be connected with an appropriate research mentor early in their training program. They will be expected to submit at least one abstract to an annual meeting (e.g., Anticoagulation Forum, THSNA, Society of Vascular Medicine).

The University of Michigan Cardiovascular Center also has multiple T32 training programs for interested trainees who would benefit from 2 additional years of research training for career development. Drs. Barnes and Kanthi are both former T32 trainees from this program. Training is available for either health services research or basic and/or translational research. Trainee experiences are structured, with a mentorship committee and formal coursework in research methodologies.

Our Faculty and Fellows

  • Geoffrey Barnes, MD, MSc, FSVM (Fellowship Director) - Dr. Barnes is board certified in vascular medicine, cardiovascular medicine, and internal medicine as well as RPVI certified. He is a national and international expert in venous thromboembolism and anticoagulation. His outpatient practice focuses on a wide range of vascular medicine disorders with an emphasis on anticoagulation and venous thromboembolism. He also serves as director of the Pulmonary Embolism Response Team. He is also a health services researcher who co-directs the Michigan Anticoagulation Quality Improvement Initiative (MAQI2) and leads NIH and AHRQ-funded research efforts improving and evaluating the delivery of anticoagulation therapy.
  • Yogen Kanthi, MD, FSVM (Fellowship Co-Director) – Dr. Kanthi is board certified in cardiovascular medicine, internal medicine, board eligible in vascular medicine, and RPVI certified. He is a national expert in thrombosis. He also runs a highly productive basic and translational research laboratory at the NIH studying inflammation and thrombosis.
  • James Froehlich, MD, MPH, FSVM – Dr. Froehlich is a national and international expert in anticoagulation, aortopathies, fibromuscular dysplasia, and perioperative care. He is a past president of the Society for Vascular Medicine. He serves as co-director for the University of Michigan Diagnostic Vascular Unit (vascular lab). His clinical practice encompasses a wide range of vascular and cardiovascular conditions. He is also the Director of the Michigan Cardiovascular Outcomes Research and Reporting Program.
  • Marion Hofmann Bowman, MD – Dr. Bowman is a cardiovascular specialist who has clinical and research expertise in aortic and genetic vascular pathology. Dr. Bowman is Medical Director of the Aortic Diseases Program at the University of Michigan Cardiovascular Center.
  • Santhi Ganesh, MD – Dr. Ganesh is a cardiovascular medicine clinician who is a national and international expert in genetic vascular disorders and fibromuscular dysplasia. She runs a highly productive basic and translational science lab focused on vasculopathy, including fibromuscular dysplasia and spontaneous coronary artery dissection. She has current and/or recent funding from the NIH and other prestigious foundation.
  • Vikas Aggarwal, MBBS, MPH – Dr. Aggarwal is a board-certified vascular medicine and cardiovascular medicine specialist who has clinical expertise in acute and chronic management of venous thromboembolism, chronic thromboembolic pulmonary hypertension, peripheral artery disease, and interventional cardiology.
  • Melvin Rubenfire, MD – Dr. Rubenfire is a board-certified cardiovascular specialist who has a clinical focus on management of preventive cardiology and hyperlipidemia.
  • Scott Visovatti, MD – Dr. Visovatti is a board-certified cardiovascular medicine specialist whose clinical practice focuses on management of pulmonary hypertension, especially chronic thromboembolic pulmonary hypertension.
  • Henry Han, MD – Dr. Han is a board eligible internal medicine physician who is currently completing his vascular medicine fellowship at the University of Michigan. He is actively involved in health services research projects focused on safe delivery of anticoagulation care under the mentorship of Dr. Barnes.

Contact Us

Bruce Skinner, Program Coordinator 
Michigan Medicine
2800 Plymouth Rd
NCRC Building 25, 2L 01N
Ann Arbor, MI 48109-2800
734-998-7500 (phone)
734-998-7711 (fax)